Health News Releases

  • Today May 15
April 01, 2021 13:20
Takeda Completes Sale of Its Japan Consumer Health Care Business Unit to Blackstone
Takeda Pharmaceutical Company Limited (TOKYO:4502) (NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of Takeda Consumer Healthcare Company Limited (“TCHC”) to Oscar
April 01, 2021 10:40
Humanigen Announces Pricing of Public Offering of Five Million Shares of Common Stock
Humanigen, Inc. (Nasdaq:HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called “cytokine storm” with its lead drug candidate
A respiratory protection mask Vo Guard
April 01, 2021 10:00
Vault Creation Launches Polymer Filter Mask Vo Guard at b8ta in US and Global Online Mall
Vault Creation, a company with unrivaled micro-etching technology, announced that it had launched Vo Guard, a respiratory protection mask to which the company’s developed eco-friendly polymer filter i
March 31, 2021 17:20
Study Shows House Wellness Foods’ Breakthrough Feed LP20® Can Advance the Potential of Rivers and Seas to Feed Our Emerging World
Vietnam is a nation that has seen its share of turmoil and suffering over the past century, and emerged from it with strength, enthusiasm, dedicated to progress and self-sufficiency. Over the past 50
March 31, 2021 16:40
Advanced Sterilization Products Announces Aisha Barry as President
Advanced Sterilization Products (ASP), a global leader in infection prevention and a wholly owned operating company of Fortive Corporation (NYSE: FTV), has named Aisha Barry the new president of ASP.
March 31, 2021 16:00
Walgreens Announces Further Expansion of its Financial Services Business Strategy with InComm Payments
Walgreens today announced an agreement with InComm Payments, a leading global payments technology company, to provide convenient and accessible financial services options for its customers. Together,
March 31, 2021 13:11
Humanigen Announces Proposed Public Offering of Five Million Shares of Common Stock
Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called “cytokine storm” with its lead drug candidat
March 30, 2021 19:55
VFMCRP and Cara Therapeutics announce European Medicines Agency has accepted to review the Marketing Authorization Application for difelikefalin
Regulatory News: Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that the European Medicines Agency (EMA) accepted to review the Market
March 30, 2021 17:25
Perspectum: High Liver Fat (Hepatic Steatosis) Linked to Increased Risk of Hospitalization in COVID-19 Patients With Obesity
New research published this month in Frontiers in Medicine (Gastroenterology) reveals that individuals with both obesity and severe fatty liver are five times more likely to require hospitalization fo
March 30, 2021 16:29
Humanigen Reports Positive Phase 3 Topline Results Demonstrating That Lenzilumab™ Improves Survival Without Need for Mechanical Ventilation in Hospitalized Patients With COVID-19
Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidat
March 30, 2021 14:40
Study Investigates the Impact of Automating Respiration Rate Measurement Using Masimo Rad-G™ with RRp®
Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Acta Paediatrica in which researchers from the Hospital for Sick Children in Toronto evaluated the
March 29, 2021 13:50
Vifor Pharma to propose Åsa Riisberg for appointment to Board of Directors
Regulatory News: Vifor Pharma is pleased to announce that the Board of Directors will propose Åsa Riisberg for election to the Board at the Annual General Meeting on 6 May 2021. Åsa Riisberg, a
March 26, 2021 17:15
AOP Orphan reports full validity of arbitral award against PharmaEssentia
Since 2017, PharmaEssentia had repeatedly attempted to terminate the agreement with AOP Orphan concerning BESREMi® (Ropeginterferon alfa-2b). After two and a half years of arbitral proceedings, in Oct
March 26, 2021 16:40
Takeda Begins Regulatory Submissions for Dengue Vaccine Candidate in EU and Dengue-Endemic Countries
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the European Medicines Agency (EMA) has accepted the Company’s filing packages for its dengue vaccine candidat
March 26, 2021 16:20
Alvotech Disputes AbbVie’s Recent Allegations
Alvotech strongly disputes AbbVie’s allegations of wrongdoing relating to AVT02, Alvotech’s proposed biosimilar to HUMIRA® (adalimumab). Alvotech will vigorously defend against these allegations. N
March 26, 2021 09:20
Brii Biosciences Closes US$155 Million Series C Financing
Brii Biosciences (“Brii Bio”), a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burden, today announced completion of
March 25, 2021 18:05
Grovara Raises $5.5 Million Seed Round to Transform Global Commerce with First B2B Global Marketplace for U.S. Healthy Brands
Grovara, the largest B2B global marketplace for U.S. natural and organic brands, announced today the closing of a $5.5 million seed round financing to transform global commerce. David Pottruck led the
March 25, 2021 16:40
Xlear Submits COVID-19 Pre-Emergency Use Authorization Request with FDA Regarding Use of Xlear Nasal Spray in Help in Combating SARS-CoV-2
Xlear has filed a Pre-Emergency Use Authorization (Pre-EUA) Request with the U.S. Food and Drug Administration (FDA) seeking approval to make claims that the nasal spray is approved for use in prevent
March 24, 2021 18:49
Boehringer Ingelheim sees positive business momentum in 2020 despite impact of COVID-19
Boehringer Ingelheim stepped up its investments in R&D significantly in 2020 in pursuit of innovative medicines and therapies for diseases for which no satisfactory treatments are available. In partic
March 23, 2021 11:50
Sri Lankan Study Expands Evidence Demonstrating the Benefits of Critical Congenital Heart Disease (CCHD) Screening Using Masimo SET® Pulse Oximetry
Masimo (NASDAQ: MASI) today announced the results of a prospective study published in the Sri Lanka Journal of Child Health in which researchers in Colombo, Sri Lanka evaluated the efficacy of a pulse
March 22, 2021 13:30
The Centers for Disease Control and Prevention (CDC) Updates Handwashing Guidelines and Materials
The Centers for Disease Control and Prevention (CDC) recently updated handwashing guidelines, standardizing language and updating visuals. Though hand dryers have always been recommended by the organi
March 22, 2021 10:40
Humanigen Sets Date for Virtual Annual Shareholders Meeting
Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidat
March 19, 2021 11:05
SpeeDx Increase Distribution Network
SpeeDx have announced signing a new distribution partner, further extending customer access to market-leading SpeeDx ResistancePlus® and PlexPCR® tests. Neogen Diagnostik Sağlık Hizmetleri Ltd Şti wil
March 18, 2021 10:40
Humanigen Expands its anti-GM-CSF Patent Portfolio
Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”) a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate
March 17, 2021 14:35
Grand Prize Winners Selected in $6M XPRIZE Rapid Covid Testing Competition to Create Fast, Frequent, Cheap, and Easy-to-Use Solutions
XPRIZE, the world’s leader in designing and operating incentive competitions to solve humanity’s grand challenges, is pleased to announce today the five winning teams in the $6M XPRIZE Rapid Covid Tes
25 per page50 per page75 per page100 per page